11.05.2023 How do human cells defend themselves against adenoviruses? The team of RESIST Professor Dr. Sabrina Schreiner from the Institute of Virology at the Hannover Medical School (MHH) has come a

10.05.2023 Glioblastomas are malignant brain tumours with a poor prognosis because they usually do not respond to common cancer therapies. One reason for this is that the tumour cells have developed m

Purinergic signaling in hepatocellular carcinoma Our group works on the relevance of extracellular purine nucleotides/nucleosides and purinergic signalling pathways in acute and chronic liver diseases

Molecular markers for gastrointestinal tumor metastasis The diagnosis of metastatic tumors often requires invasive procedures such as biopsy, endoscopy, or diagnostic laparoscopy. However, tumors at d

The Role of Purinergic Immune Regulation in the Peritoneal Tumor Microenvironment Purinergic signaling pathways, which include the ectonucleotidases ENTPD1 (CD39) and ENTPD3, are critically involved i

Prof. Dr. Christoph Schindler (ZKS) at the EWMA Congress 2023 At this year's European Wound Management Association Congress in Milan, Prof. Schindler presented the results of the Aurealis Therapeutics

08.05.2023 MHH has awarded a total of 105 doctoral degrees since November 2022: 76 female and 29 male doctoral students of Hannover Medical School (MHH) received their doctoral certificates on Friday.

Kidney aging and regeneration Research Group Leader Prof. Dr. med. Roland Schmitt Research Assistants Dr. rer. nat. Inga Sörensen-Zender Dr. med. Vera Wulfmeyer Dr. med. Nikolai Rex Blanca de Juan, Ph

Molecular basis of rare and genetic kidney diseases Research Group Leader Dr. med. Svjetlana Lovric Research Assistants Dr. rer. nat. Irini Schäfer, Research Assistant Fatih Türk, Doktorand (cand. med

W2 Professorship for Experimental Vascular Medicine Research Group Leader Prof. Dr. med. Florian P. Limbourg Research Assistants Jaba Gamrekelashvili, PhD Dr. rer. nat. Tamar Kapanadze Dr. med. Christ